HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Generalized gangliosidosis: beta-galactosidase deficiency.

Abstract
A profound deficiency (10- to 30-fold) of beta-galactosidase activity was found in tissues (liver, spleen, kidney, and brain) from two patients with generalized gangliosidosis; this deficiency is demonstrated as a failure to cleave both p-nitrophenyl-beta-D-galactopyranoside and ganglioside GM(1) labeled with C(14) in the terminal galactose. We believe that this enzymic defect is responsible for the accumulation of ganglioside GM(1) and is the fundamental enzyme defect in generalized gangliosidosis.
AuthorsS Okada, J S O'Brien
JournalScience (New York, N.Y.) (Science) Vol. 160 Issue 3831 Pg. 1002-4 (May 31 1968) ISSN: 0036-8075 [Print] United States
PMID5647842 (Publication Type: Journal Article)
Chemical References
  • Carbon Isotopes
  • Gangliosides
  • Glycosides
  • Nitrophenols
  • Uracil Nucleotides
  • Acid Phosphatase
  • Galactosidases
  • Glucosidases
  • Galactose
Topics
  • Acid Phosphatase (metabolism)
  • Aged
  • Brain (enzymology)
  • Carbon Isotopes
  • Child
  • Child, Preschool
  • Chromatography, Paper
  • Galactose (metabolism)
  • Galactosidases (metabolism)
  • Gangliosides (analysis, metabolism)
  • Glucosidases (metabolism)
  • Glycosides (metabolism)
  • Humans
  • Infant
  • Kidney (enzymology)
  • Lipid Metabolism, Inborn Errors
  • Lipidoses
  • Liver (enzymology)
  • Male
  • Middle Aged
  • Molecular Biology
  • Niemann-Pick Diseases
  • Nitrophenols
  • Spleen (enzymology)
  • Uracil Nucleotides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: